Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer
Article in Oncology Letters (November 2023)
The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.
A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
Article in BMC Pulmonary Medicine (November 2023)
A real-world study of recombinant human endostatin combined with PD-1/PD-L1 blockade and chemotherapy for patients with advanced non-small cell lung cancer negative for actionable molecular biomarkers
Article in Medicine (October 2023)